CLASS 46
Now in its twelfth year, Class 46 is dedicated to European trade mark law and practice. This weblog is written by a team of enthusiasts who want to spread the word and share their thoughts with others.
Want to receive Class 46 by email?
Click here subscribe for free.
Click here subscribe for free.
Who we all are...
TUESDAY, 1 MARCH 2011
Greece - Nurofen ad causes headaches
The Greek Communication Review Board has asked Reckitt Benckiser Hellas to amend its TV communication for the NUROFEN pain-relief medicinal product, following a complaint lodged by GlaxoSmithKline. The Board reviewed the advertising claim that "99% of those who use it, trust NUROFEN for immediate relief from headache" and held that it falls short of the requirements prescribed by the self-regulatory Greek Code of Advertisement - Communication. In particular, the Board held that the ad does not provide subastantive data of the survey conducted to substantiate the said claim and, accordingly, could mislead consumers. In its decision (No. A-432), the Board further held that if Reckitt Benckiser Hellas were to incorporate 'banners' in the video of the advertisement to provide such data, then the banners should capture at least 10% of the screen size.
Posted by: Nikos Prentoulis @ 14.18
Tags: Greece, advertisement, Communication Review Board, Neurofen, GlaxoSmithKline, health products,
Sharing on Social Media? Use the link below...
Perm-A-Link: https://www.marques.org/blogs/class46?XID=BHA2268
Greece - Nurofen ad causes headaches
Tags: Greece, advertisement, Communication Review Board, Neurofen, GlaxoSmithKline, health products,
Sharing on Social Media? Use the link below...Perm-A-Link: https://www.marques.org/blogs/class46?XID=BHA2268
Reader Comments: 0
Post a Comment
MARQUES does not guarantee the accuracy of the information in this blog. The views are those of the individual contributors and do not necessarily reflect those of MARQUES. Seek professional advice before action on any information included here.
The Class 46 Archive
